Greenwich LifeSciences has shared important updates on the phase 3 Flamingo-01 trial, which is researching GLSI-100, a new immunotherapy for patients with a specific...
Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...
A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...
Today we wanted to point to an outstanding interview with Dr. Nicholas P. McAndrew, an expert in breast cancer treatment.
He recently shared insights on...